Picture of Fulgent Genetics logo

FLGT — Fulgent Genetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Fulgent Genetics Inc expected to post earnings of 5cents a share - Earnings Preview

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
7. 
    * The Temple City California-based  company is expected to
report 
a 59.9% decrease in revenue to $91.36 million from $227.87
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. The company's guidance on
August 4 2022, for the period ended September 30, was for
revenue of $54.000 million.
    * ​Refinitiv's mean analyst estimate for Fulgent Genetics
Inc is
for earnings of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $67.5​, above​ its last closing price of $37.98. ​​​

This summary was machine generated November 5 at 03:05 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Fulgent Genetics

See all news